Bath & Body Works opened higher at $21.79, compared with its previous close of $21.72. In the last trading session, the stock traded between $21.04 and $21.81. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Bath & Body Works is now worth
$ 27.89
Resulting in a loss of
$ 72.11 (72.11%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 16 Analysts
Buy
25%
Hold
68.75%
Sell
6.25%
Markets Today
Today's Change
$-0.63 (-2.89%)
Day High
$21.81
Day Low
$21.04
Day Open
$21.79
Prev Close
$21.72
Volume
35,76,714
1W Return
-10.46%
1M Return
21.06%
3M Return
11.68%
6M Return
10.09%
1Y Return
-3.95%
Fundamentals
Market Cap ($ Mn)
4,253
PE Ratio
5.06
PB Ratio
-
PEG Ratio
13.58
ROE
-
ROCE
32.80%
EPS (TTM)
$0.58
Investment Returns
1 Week
-10.46%
1 Month
21.06%
3 Months
11.68%
6 Months
10.09%
9 Months
-5.88%
Financials
Quarterly
All values in $ Mn
1.4K
Apr 25
1.5K
Jul 25
1.6K
Oct 25
2.7K
Jan 26
1.4K
Apr 26
1.5K
Jul 26
Updates
16Sep
Argus Research reiterates Hold rating on Bath & Body Works
Argus Research reiterates Hold rating on Bath & Body Works (NYSE: BBWI). Analyst Taylor Conrad confirms the neutral stance. No price target adjustments or new estimates disclosed.
1mo ago
11Sep
Barington takes new stake in Bath & Body Works, pushes for sale
Barington acquires additional stake in Bath & Body Works. Firm actively pushing for sale of the retailer. No financial terms disclosed in source.
2mo ago
27Aug
UBS maintains Neutral on Bath & Body Works, cuts price target to $17
UBS analyst Jay Sole maintains a Neutral rating on Bath & Body Works. Price target lowered from $19 to $17. No change in overall investment stance despite lower valuation ceiling.
2mo ago
27Aug
Barclays cuts Bath & Body Works price target to $22
Barclays lowers Bath & Body Works price target to $22. Previous target was set at $23 per share. Equal-Weight rating remains unchanged. Analyst Adrienne Yih issued the update.
2mo ago
27Aug
Bath & Body Works Q2 EPS beats; analysts slash price targets
Bath & Body Works Q2 adj EPS $0.62 beats consensus $0.24; sales $1.514B beat estimates. Full-year adj EPS guidance raised to $2.60-$2.80; GAAP EPS guide lifted to $3.13-$3.33. Morgan Stanley, Wells Fargo, and UBS analysts slashed price targets following results. $80M tariff refund boosted margins; underlying gross margin down 90 bps YoY. Shares fell 2.9% to $18.36 despite earnings beat and raised guidance.
2mo ago
26Aug
Bath & Body Works raises FY26 adj EPS guidance to $2.60-$2.80
Bath & Body Works raises FY26 adjusted EPS guidance to $2.60-$2.80 vs $2.65 estimate. Narrows FY26 sales guidance to $6.999B-$7.109B vs $7.095B analyst estimate. Q2FY26 adjusted EPS rose to $0.62 from $0.37 in prior year. Company forecasts $650 million free cash flow for fiscal 2026.
